guaifenesin has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, V | 1 |
| Sunder, S | 1 |
| Verma, SR | 1 |
| Shi, Y | 1 |
| Liu, L | 1 |
| Yin, M | 1 |
| Zhao, Z | 1 |
| Liang, Y | 1 |
| Sun, K | 1 |
| Li, Y | 1 |
| Sintsova, O | 1 |
| Gladkikh, I | 1 |
| Kalinovskii, A | 1 |
| Zelepuga, E | 1 |
| Monastyrnaya, M | 1 |
| Kim, N | 1 |
| Shevchenko, L | 1 |
| Peigneur, S | 1 |
| Tytgat, J | 1 |
| Kozlovskaya, E | 1 |
| Leychenko, E | 1 |
1 review available for guaifenesin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.
Topics: COVID-19; Diabetes Mellitus, Type 2; Dysbiosis; Gastrointestinal Microbiome; Humans; Mucins; Mucus; | 2022 |
2 other studies available for guaifenesin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment.
Topics: Administration, Oral; Animals; Chitosan; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dru | 2023 |
Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone
Topics: alpha-Amylases; Amino Acid Sequence; Animals; beta-Defensins; Blood Glucose; Cnidarian Venoms; Diabe | 2019 |